PHIO RXi Pharmaceuticals: Bathi sing dikarepake

Tandha merek Phio Pharmaceuticals Corp (PHIO)

Phio Pharmaceuticals (PHIO) is developing an immuno-oncology environment based on RNA interference, creating exclusive treatment protocols. The current valuation of future earnings illustrates the business's adaptability to costs, where 0.02 reflects the latest metric value. Fundamental gene-silencing patents ensure a high barrier to entry for third-party players, while the implementation of laboratory robotics automates predictive data analysis.

PHIO - Penghasilan resik sing dikarepake RXi Pharmaceuticals ing rentang 04.07.2022 - 31.03.2025

Phio Pharmaceuticals Corp - rincian analitis lan metrik utama (PHIO)

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:PHIO, Phio Pharmaceuticals Corp
Produk dadi Phio Pharmaceuticals Corp.

When assessing the resilience of Phio Pharmaceuticals (PHIO) to market downturns, it is critical to consider the absence of current revenue. Business stability is underpinned by a unique RNA interference platform designed to combat tumors. The extrapolation of future profits here reflects the daily market consensus regarding upcoming financial results, smoothing the gaps between reports. This metric measures investor expectations, transforming static balance sheet data into a dynamic forecast. High indicator values may signal an overvaluation of the asset.

Analisis pesaing Phio Pharmaceuticals

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Proyeksi bathi resik Ultragenyx (RARE)|BEAM: Proyeksi bathi mangsa ngarep|Sarepta Therapeutics, Inc. (SRPT) - Proyeksi bathi mangsa ngarep|TWST (twistbioscience.com) - Proyeksi bathi mangsa ngarep|10x Genomics, Inc. (TXG) - Prakiraan bathi perusahaan|Bathi mangsa ngarep NTLA (Intellia Therapeutics, Inc.)|STOK - Bathi resik sing dikarepake|Bathi sing dikarepake biolifesolutions.com BLFS|Prakiraan bathi perusahaan Wave Life Sciences Corp (WVE)|MAZE - Bathi sing dikarepake|Penghasilan resik sing dikarepake SION (Sionna Therapeutics Inc)|PRME: Proyeksi bathi mangsa ngarep|Taysha - Penghasilan resik sing dikarepake|Bathi sing dikarepake uniQure NV|Prakiraan bathi resik MGTX (MeiraGTx PLC)|Bathi mangsa ngarep RGNX (regenxbio.com)|Solid Biosciences Inc. - Prakiraan bathi resik|Bathi sing dikarepake Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Bathi resik sing dikarepake|BNTC - Bathi sing dikarepake|Design Pharma - Bathi resik mangsa ngarep|RCKT (Rocket Pharmaceuticals Inc) - Bathi mangsa ngarep|4D Molecular Therapeutics (FDMT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Lexeo Therapeutics, Inc.|Bathi resik sing dikarepake Korro Bio, Inc. KRRO|Proyeksi bathi mangsa ngarep EDIT|Prakiraan bathi perusahaan Silence Therapeutics Corp|Bathi sing dikarepake proqr.com PRQR|CDXS - Bathi mangsa ngarep|SGMO - Bathi sing dikarepake|Proyeksi bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik DTIL|GBIO (Generation Bio) - Proyeksi bathi mangsa ngarep|Prakiraan bathi resik BOLD (boundlessbio.com)|Bathi mangsa ngarep XCUR (exicuretx.com)|Celsion Corporation - Prakiraan bathi resik|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep